These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35130782)

  • 1. Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Femoropopliteal Arterial Disease.
    Stavroulakis K; Bisdas T; Torsello G; Tsilimparis N; Damerau S; Argyriou A
    J Endovasc Ther; 2023 Feb; 30(1):106-113. PubMed ID: 35130782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [No Abstract]   [Full Text] [Related]  

  • 3. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K; Torsello G; Chlouverakis G; Bisdas T; Damerau S; Tsilimparis N; Argyriou A
    J Endovasc Ther; 2023 Mar; ():15266028231158313. PubMed ID: 36896876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial.
    Tepe G; Brodmann M; Werner M; Bachinsky W; Holden A; Zeller T; Mangalmurti S; Nolte-Ernsting C; Bertolet B; Scheinert D; Gray WA;
    JACC Cardiovasc Interv; 2021 Jun; 14(12):1352-1361. PubMed ID: 34167675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Rocha-Singh KJ; Sachar R; DeRubertis BG; Nolte-Ernsting CCA; Winscott JG; Krishnan P; Scott EC; Garcia LA; Baeriswyl JL; Ansel G; Rosenfield K; Zeller T;
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):549-558. PubMed ID: 34080792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midterm Outcomes of Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions in a Daily Practice Cohort.
    Nugteren M; Serné A; Verhoeven B; Koning O; van den Haak R; Scholtes V; Hinnen JW
    Ann Vasc Surg; 2020 Apr; 64():188-197. PubMed ID: 31634609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty.
    Giannopoulos S; Strobel A; Rudofker E; Kovach C; Kokkosis AA; Armstrong EJ
    J Endovasc Ther; 2023 Apr; 30(2):194-203. PubMed ID: 35179065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shockwave™ Lithoplasty in Combination With Atherectomy in Treating Severe Calcified Femoropopliteal and Iliac Artery Disease: A Single-Center Experience.
    Radaideh Q; Shammas NW; Shammas WJ; Shammas GA
    Cardiovasc Revasc Med; 2021 Jan; 22():66-70. PubMed ID: 32563711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jul; 66():595-600. PubMed ID: 31863948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
    Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results.
    Cioppa A; Stabile E; Popusoi G; Salemme L; Cota L; Pucciarelli A; Ambrosini V; Sorropago G; Tesorio T; Agresta A; Biamino G; Rubino P
    Cardiovasc Revasc Med; 2012; 13(4):219-23. PubMed ID: 22632996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after paclitaxel-coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study.
    Ko YG; Choi D; Rha SW; Won JH; Do YS; Lee SW; Menk JS; Kum S
    Catheter Cardiovasc Interv; 2022 Dec; 100(7):1273-1283. PubMed ID: 36385562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.